Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.

Rovin, Brad H; Furie, Richard; Latinis, Kevin; Looney, R John; Fervenza, Fernando C; Sanchez-Guerrero, Jorge; Maciuca, Romeo; Zhang, David; Garg, Jay P; Brunetta, Paul; Appel, Gerald

Rovin, Brad H; Furie, Richard; Latinis, Kevin; Looney, R John; Fervenza, Fernando C; Sanchez-Guerrero, Jorge; Maciuca, Romeo; Zhang, David; Garg, Jay P; Brunetta, Paul; Appel, Gerald.

Affiliation

Rovin BH; Ohio State University, Columbus, OH 43210, USA. Brad.Rovin@osumc.edu

Arthritis Rheum ; 64(4): 1215-26, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22231479

Subject(s)

Antibodies, Monoclonal, Murine-Derived/therapeutic use; Immunosuppressive Agents/therapeutic use; Lupus Nephritis/drug therapy; Adolescent; Adrenal Cortex Hormones/therapeutic use; Adult; Aged; Antibodies, Monoclonal, Murine-Derived/adverse effects; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents/adverse effects; Male; Middle Aged; Mycophenolic Acid/analogs & derivatives; Mycophenolic Acid/therapeutic use; Rituximab; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Antibodies, Monoclonal, Murine-Derived / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google